Public Profile

Teva Branded Pharmaceutical Products R&D, Inc.

Teva Branded Pharmaceutical Products R&D, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd., is a leading player in the global pharmaceutical industry, headquartered in the United States. Founded in 1901, Teva has established itself as a pioneer in the development and manufacturing of generic and specialty medicines, with a strong focus on therapeutic areas such as central nervous system disorders, respiratory conditions, and oncology. With major operational regions across North America, Europe, and beyond, Teva is renowned for its extensive portfolio of high-quality medications. The company’s commitment to innovation is evident in its robust research and development efforts, which have led to numerous key milestones, including the launch of several groundbreaking treatments. Teva's unique approach to drug development and its market position as one of the largest generic drug manufacturers underscore its significant contributions to improving patient outcomes worldwide.

DitchCarbon Score

How does Teva Branded Pharmaceutical Products R&D, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

82

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

49

Industry Benchmark

Teva Branded Pharmaceutical Products R&D, Inc.'s score of 82 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.

53%

Let us know if this data was useful to you

Teva Branded Pharmaceutical Products R&D, Inc.'s reported carbon emissions

Inherited from Teva Pharmaceutical Industries Limited

Teva Branded Pharmaceutical Products R&D, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Teva Pharmaceutical Industries Limited, any climate commitments or emissions data would be inherited from this parent organisation. Teva Pharmaceutical Industries Limited has established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for Teva Branded Pharmaceutical Products R&D, Inc. have not been detailed in the available information. As part of its corporate family, Teva Branded Pharmaceutical Products R&D, Inc. aligns with the broader sustainability goals of Teva Pharmaceutical Industries Limited, which may include commitments to reduce greenhouse gas emissions across all scopes. Nonetheless, without specific emissions data or reduction targets, the current climate commitments remain vague. In summary, while Teva Branded Pharmaceutical Products R&D, Inc. is part of a larger organisation with climate initiatives, detailed emissions data and specific reduction targets for this subsidiary are not currently available.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201320142015201620172018201920202021202220232024
Scope 1
438,420,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
613,541,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
-
-
-
-
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Teva Branded Pharmaceutical Products R&D, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Teva Branded Pharmaceutical Products R&D, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Teva Branded Pharmaceutical Products R&D, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Sandoz S.R.L.

RO
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Eisai

JP
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Genentech

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Merck Santé S.A.S.

FR
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Takeda

JP
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Alkermes

IE
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers